Effectiveness of in insulin resistance correction and the adipokines level reduction in patients with arterial hypertension in comparison with other ARBs

Effectiveness of in insulin resistance correction and the adipokines level reduction in patients with arterial hypertension in comparison with other ARBs

Aim. To assess the possibility of azilsartan medoxomil to achieve target blood pressure (BP) (less than 130/80 mm Hg), to study angioprotective features and reduction of adipokines levels and inflammatory markers in patients with hypertension and previous therapy with other ARBs.Material and methods...

Full description

Bibliographic Details
Main Authors:	S. V. Nedogoda, E. V. Chumachek, V. V. Tsoma, A. S. Salasyuk, V. O. Smirnova, E. A. Popova
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2019-02-01
Series:	Российский кардиологический журнал
Subjects:	arterial hypertension pulse wave velocity central blood pressure augmentation index adipokines azilsartan
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/3097

Similar Items

Azilsartan medoxomil for improving insulin resistance and adipokine levels in hypertension in comparison with angiotensin-converting enzyme inhibitors
by: S. V. Nedogoda, et al.
Published: (2020-08-01)

ADDITIONAL ANGIOPROTECTION AND METAbOLIC DISORDERS CORRECTION IN TREATMENT OF ARTERIAL HYPERTENSION PATIENTS REACHED TARGET bLOOD PRESSURE LEVELS, WITH FIxED COMbINATION OF PERINDOPRIL AND INDAPAMIDE
by: S. V. Nedogod, et al.
Published: (2018-05-01)

Improving blood pressure control, organoprotection and metabolic disorders correction in patients with hypertension switching from diuretic-based combinations to fixed combination lisinopril + amlodipine + rosuvastatin
by: S V Nedogoda, et al.
Published: (2018-06-01)

OPTIMAL ORGANOPROTECTION, CONTROL OF bLOOD PRESSURE AND METAbOLIC DISORDER WITH THE FIxED COMbINATION OF LISINOPRIL, AMLODIPINE AND ROSUVASTATIN IN SYSTEMIC HYPERTENSION
by: S. V. Nedogoda, et al.
Published: (2018-05-01)

The effect of various classes of glucose-lowering medications on the blood vessel elasticity in patients with type 2 diabetes
by: S. V. Nedogoda, et al.
Published: (2020-05-01)

Optimal Organ Protection and Blood Pressure Control with the Single Pill Combination Lisinopril, Amlodipine and Indapamide in Arterial Hypertension
by: S. V. Nedogoda, et al.
Published: (2020-12-01)

Optimization of blood pressure control, organ protection and metabolic disorders using a fixed-dose combination of lisinopril+amlodipine+rosuvastatin in hypertensive patients after COVID-19
by: S. V. Nedogoda, et al.
Published: (2022-01-01)

COMPARATIVE EFFECTIVENESS OF PERINDOPRIL AND LOSARTAN IN PATIENTS WITH ARTERIAL HYPERTENSION AND OBESITY
by: S. V. Nedogoda, et al.
Published: (2012-02-01)

The abilities of losartan in angioprotection in hypertensive patients with hyperuricemia
by: S V Nedogoda, et al.
Published: (2012-12-01)

Modern fixed combinations of antihypertensive drugs in the treatment of arterial hypertension and obesity: can this comorbid pathology be effectively controlled?
by: Yu. A. Vasyuk, et al.
Published: (2019-09-01)

Efficacy of azilsartan medoxomil in patients with hypertension and stable coronary artery disease in combination with type 2 diabetes
by: A. M. Kochergina, et al.
Published: (2023-11-01)

Full spectrum and genetic algorithm-selected spectrum-based chemometric methods for simultaneous determination of azilsartan medoxomil, chlorthalidone, and azilsartan: Development, validation, and application on commercial dosage form
by: Darwish Hany W., et al.
Published: (2021-03-01)

The possibility of a new receptor blocker to angiotensin in improving control of hypertension. Non-intervention international multicenter observational prospective study of the use azilsartan medoxomil in patients with arterial hypertension and overweight or obesity in the Russian Federation and the Republic of Kazakhstan
by: Yu V Zhernakova, et al.
Published: (2016-09-01)

Adipokines mediate inflammation and insulin resistance
by: Jeffrey E. Pessin, et al.
Published: (2013-06-01)

The treatment options of the new angiotensin II receptor blocker - azilsartan medoxomil in the therapy of hypertension in patients with metabolic disorders
by: Yu V Zhernakov, et al.
Published: (2014-12-01)

The possibility of a new receptor blocker to angiotensin in improving control of hypertension. Non-intervention international multicenter observational prospective study of the use azilsartan medoxomil in patients with arterial hypertension and overweight
by: Zhernakova Yu.V., et al.
Published: (2016-12-01)

Effects of two different angiotensin receptor blockers on blood glucose level and HbA1c in type-2 diabetes mellitus patients with hypertension
by: Shafat Iqbal Bhati, et al.
Published: (2023-10-01)

The Role of Adipokines in Inflammatory Mechanisms of Obesity
by: Tatiana V. Kirichenko, et al.
Published: (2022-11-01)

MODERN OPPORTUNITIES FOR ANTIHYPERTENSION THERAPY: THE PLACE OF AZILSARTAN MEDOXOMIL
by: V. V. Skibitsky, et al.
Published: (2017-12-01)

The Correlation between Waist Circumference and the Pro-Inflammatory Adipokines in Diabetic Retinopathy of Type 2 Diabetes Patients
by: Yeo Jin Lee, et al.
Published: (2023-01-01)

Adipokines and the metabolism of key nutrients in patients with obesity
by: O O Kirillova, et al.
Published: (2014-01-01)

Comparative analysis of cardiovascular system morphofunctional disorders’ correction in a simulated metabolic syndrome
by: Cyril O. Tarimov, et al.
Published: (2020-09-01)

Effects of Bariatric Surgery on Adipokine-Induced Inflammation and Insulin Resistance
by: Zeynep eGoktas, et al.
Published: (2013-06-01)

Estimation of arterial rigidity parameters in patients with gout and essential hypertension
by: E V Klinkova, et al.
Published: (2010-12-01)

Features of cytokine and adipokine regulation in asthma associated with obesity
by: Alla V. Yurenko, et al.
Published: (2019-06-01)

INFLUENCE OF ANTIHYPERTENSIVE DRUGS ON ARTERIAL STIFFNESS IN PATIENTS WITH ARTERIAL HYPERTENSION
by: N. V. Egorkina, et al.
Published: (2016-01-01)

The possibility of perindopril in angioprotective in patients with metabolic syndrome after combination therapy with a thiazide diuretic
by: S V Nedogoda, et al.
Published: (2016-03-01)

An alternative synthesis of Azilsartan: an angiotensin II receptor blocker
by: Garaga Srinivas, et al.
Published: (2015-06-01)

Synthesis and characterization of related substances of Azilsartan Kamedoxomil
by: Maddi N. V. D. Harikiran, et al.
Published: (2017-03-01)

Effectiveness of antihypertensive agents in stage I/II hypertensive patients with ace (I/D) gene polymorphism
by: Bansal G, et al.
Published: (2023-01-01)

Obesity and Inflammation: Role of Adipokines
by: Majid Khazaei, et al.
Published: (2016-04-01)

Treatment of arterial hypertension in metabolic syndrome in men with erectile dysfunction
by: S. V. Nedogoda, et al.
Published: (2013-12-01)

Adipokines and Insulin Resistance According to Characteristics of Pregnant Women with Gestational Diabetes Mellitus
by: Eon Ju Jeon, et al.
Published: (2017-11-01)

Adipokines in pulmonary hypertension: angels or demons?
by: Qi Jia, et al.
Published: (2023-11-01)

Adipokines in rheumatoid arthritis
by: Elis Carolina de Souza Fatel, et al.
Published: (2018-08-01)

Radial Pulse Wave Analysis in Young Male Elite Athletes
by: Fernando Clara, et al.
Published: (2020-12-01)

The Role of Adipokines in the Control of Pituitary Functions
by: Barbara Kaminska, et al.
Published: (2024-01-01)

Prospects of potential adipokines as therapeutic agents in obesity-linked atherogenic dyslipidemia and insulin resistance
by: Probin Kr Roy, et al.
Published: (2023-04-01)

The role of adipokines in skeletal muscle inflammation and insulin sensitivity
by: Thomas Nicholson, et al.
Published: (2018-05-01)

Obesity-Related Adipokines Predict Patient-Reported Shoulder Pain
by: Rajiv Gandhi, et al.
Published: (2013-12-01)